Comparison of Three Reconstitution Devices: A Simulated Time and Use Study.

Q4 Medicine International journal of pharmaceutical compounding Pub Date : 2023-03-01
Daleen Penoyer, Karen Giuliano, Aurea Middleton
{"title":"Comparison of Three Reconstitution Devices: A Simulated Time and Use Study.","authors":"Daleen Penoyer,&nbsp;Karen Giuliano,&nbsp;Aurea Middleton","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The objective of this study was to compare residual volume and time to prepare and reconstitute cefazolin using 3 different reconstitution devices while observing for use errors, participant feedback, and particulate after reconstitution. After demonstrations on the use of each device and practicing twice with each device, participants performed reconstitutions 3 times per device while being timed and observed on device preparation and assembly, mixing the drug with intravenous fluid into vials, and transfer of vial contents into the intravenous bags. Participants completed surveys to assess perceptions on use of each device. Intravenous bags were then hung for 60 minutes and observed for residual fluid and particulate matter. Residual vial volumes ranged from 0.05 mL to 2.6 mL: >0.3 mL in Device 2 (16.7%), Device 1 (55.6%), and Device 3 (81.1%). Most participants (83%) had experience with Device 1. Mean (standard deviation) total time in seconds to reconstitute medication significantly differed between devices (P<0.001): Device 1, 70.98 (15.72), Device 2, 99.11 (14.87), Device 3, 103.7 (18.99). Device assembly took the longest time and significantly differed between devices (P<0.001): Device 1, 18.76 (8.13), Device 2, 36.09 (8.05), and Device 3, 31.21 (7.75). Survey results (60=max score) were significantly different (P<0.001): Device 1, 54.5 (5.3), Device 2, 44 (13.1), Device 3, 37.1 (9.1). Nurses ranked Device 1 the highest (79%) and pharmacy technicians favored Device 2 (60%). No particulates were found (n = 270). Potentially significant residual vial volume was found and use errors were concerning in Device 2 and Device 3, potentially resulting in incomplete medication dosing. Mean times for reconstitution were <104 seconds, with Device 1 being the fastest and most favored.</p>","PeriodicalId":14381,"journal":{"name":"International journal of pharmaceutical compounding","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmaceutical compounding","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The objective of this study was to compare residual volume and time to prepare and reconstitute cefazolin using 3 different reconstitution devices while observing for use errors, participant feedback, and particulate after reconstitution. After demonstrations on the use of each device and practicing twice with each device, participants performed reconstitutions 3 times per device while being timed and observed on device preparation and assembly, mixing the drug with intravenous fluid into vials, and transfer of vial contents into the intravenous bags. Participants completed surveys to assess perceptions on use of each device. Intravenous bags were then hung for 60 minutes and observed for residual fluid and particulate matter. Residual vial volumes ranged from 0.05 mL to 2.6 mL: >0.3 mL in Device 2 (16.7%), Device 1 (55.6%), and Device 3 (81.1%). Most participants (83%) had experience with Device 1. Mean (standard deviation) total time in seconds to reconstitute medication significantly differed between devices (P<0.001): Device 1, 70.98 (15.72), Device 2, 99.11 (14.87), Device 3, 103.7 (18.99). Device assembly took the longest time and significantly differed between devices (P<0.001): Device 1, 18.76 (8.13), Device 2, 36.09 (8.05), and Device 3, 31.21 (7.75). Survey results (60=max score) were significantly different (P<0.001): Device 1, 54.5 (5.3), Device 2, 44 (13.1), Device 3, 37.1 (9.1). Nurses ranked Device 1 the highest (79%) and pharmacy technicians favored Device 2 (60%). No particulates were found (n = 270). Potentially significant residual vial volume was found and use errors were concerning in Device 2 and Device 3, potentially resulting in incomplete medication dosing. Mean times for reconstitution were <104 seconds, with Device 1 being the fastest and most favored.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
三种重构装置的比较:模拟时间和使用研究。
本研究的目的是比较使用3种不同重构装置制备和重构头孢唑林的残留量和时间,同时观察使用错误、参与者反馈和重构后的颗粒。在演示了每个装置的使用方法并使用每个装置进行了两次练习后,参与者对每个装置进行了3次重构,同时对装置的制备和组装进行了计时和观察,将药物与静脉输液混合到小瓶中,并将小瓶内容物转移到静脉注射袋中。参与者完成了调查,以评估对每种设备使用的看法。静脉输液袋悬挂60分钟,观察残余液体和颗粒物。器械2(16.7%)、器械1(55.6%)和器械3(81.1%)的剩余瓶体积范围为0.05 mL至2.6 mL: >0.3 mL。大多数参与者(83%)使用过Device 1。平均(标准差)总时间(秒)重建药物显着不同的设备(P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
62
期刊介绍: The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today"s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.
期刊最新文献
Crushability Analysis of Immediate-Release Oral Tablets and Capsules from the 2020-22 FDA Novel Drug Approvals. Enhancing Hormonal Tablets Disintegration: The Role of Chitosan as an Alternative Disintegrant in Estradiol Tablet Formulation. Pharmaceutical Waters Used in Sterile and Nonsterile Compounding. Comparison of Oven Dried and Freeze Dried Orally Disintegrating Film (ODF) Formulations Containing Memantine Hydrochloride. Compatibility of Active Pharmaceutical Ingredients in Cleoderm™: A Comprehensive Study for Enhanced Topical Dermatological Treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1